Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Xpo7 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Xpo7 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of XPO7 mRNA | CTD | PMID:17942748 | Xpo7 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Xpo7 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Xpo7 | Rat | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Xpo7 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Xpo7 | Rat | 2,3',4,4',5-Pentachlorobiphenyl | decreases expression | ISO | Xpo7 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | Xpo7 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Xpo7 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of XPO7 mRNA | CTD | PMID:21570461 | Xpo7 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of XPO7 mRNA | CTD | PMID:21215274 | Xpo7 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Xpo7 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of XPO7 mRNA | CTD | PMID:20188158 | Xpo7 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | XPO7 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of XPO7 protein | CTD | PMID:34186270 | Xpo7 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of XPO7 mRNA | CTD | PMID:30047161 | Xpo7 | Rat | acrolein | multiple interactions | ISO | XPO7 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPO7 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 | Xpo7 | Rat | aflatoxin B1 | increases methylation | ISO | XPO7 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of XPO7 gene | CTD | PMID:27153756 | Xpo7 | Rat | all-trans-retinoic acid | decreases expression | ISO | XPO7 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of XPO7 mRNA | CTD | PMID:18614847 | Xpo7 | Rat | alpha-pinene | multiple interactions | ISO | XPO7 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPO7 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPO7 mRNA | CTD | PMID:32699268 | Xpo7 | Rat | amiodarone | decreases expression | EXP | | 6480464 | Amiodarone results in decreased expression of XPO7 mRNA | CTD | PMID:17991464 | Xpo7 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of XPO7 mRNA | CTD | PMID:30047161 | Xpo7 | Rat | aristolochic acid A | decreases expression | ISO | XPO7 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of XPO7 mRNA | CTD | PMID:33212167 | Xpo7 | Rat | atrazine | increases expression | ISO | Xpo7 (Mus musculus) | 6480464 | Atrazine results in increased expression of XPO7 mRNA | CTD | PMID:26518232 | Xpo7 | Rat | benzatropine | multiple interactions | ISO | XPO7 (Homo sapiens) | 6480464 | [Cuprizone co-treated with Benztropine] results in increased expression of XPO7 protein | CTD | PMID:34122009 | Xpo7 | Rat | benzo[a]pyrene | affects methylation | ISO | XPO7 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of XPO7 promoter | CTD | PMID:27901495 | Xpo7 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of XPO7 mRNA | CTD | PMID:25181051 | Xpo7 | Rat | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of XPO7 mRNA | CTD | PMID:32479839 | Xpo7 | Rat | cadmium atom | multiple interactions | ISO | XPO7 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of XPO7 mRNA | CTD | PMID:35301059 | Xpo7 | Rat | cadmium dichloride | multiple interactions | ISO | XPO7 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of XPO7 mRNA | CTD | PMID:35301059 | Xpo7 | Rat | calcitriol | decreases expression | ISO | XPO7 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of XPO7 mRNA | CTD | PMID:16847355 and PMID:18614847 | Xpo7 | Rat | cannabidiol | decreases expression | ISO | XPO7 (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of XPO7 protein | CTD | PMID:34122009 | Xpo7 | Rat | CGP 52608 | multiple interactions | ISO | XPO7 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to XPO7 gene] | CTD | PMID:28238834 | Xpo7 | Rat | choline | multiple interactions | ISO | Xpo7 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of XPO7 gene | CTD | PMID:20938992 | Xpo7 | Rat | clofibrate | multiple interactions | ISO | Xpo7 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of XPO7 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of XPO7 mRNA] | CTD | PMID:17585979 | Xpo7 | Rat | coumestrol | increases expression | ISO | XPO7 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of XPO7 mRNA | CTD | PMID:19167446 | Xpo7 | Rat | Cuprizon | multiple interactions | ISO | XPO7 (Homo sapiens) | 6480464 | [Cuprizone co-treated with Benztropine] results in increased expression of XPO7 protein | CTD | PMID:34122009 | Xpo7 | Rat | entinostat | decreases expression | ISO | XPO7 (Homo sapiens) | 6480464 | entinostat results in decreased expression of XPO7 mRNA | CTD | PMID:27188386 | Xpo7 | Rat | finasteride | increases expression | EXP | | 6480464 | Finasteride results in increased expression of XPO7 mRNA | CTD | PMID:24136188 | Xpo7 | Rat | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of XPO7 mRNA | CTD | PMID:34044035 | Xpo7 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of XPO7 mRNA | CTD | PMID:24136188 | Xpo7 | Rat | folic acid | multiple interactions | ISO | Xpo7 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of XPO7 gene | CTD | PMID:20938992 | Xpo7 | Rat | folpet | increases expression | ISO | Xpo7 (Mus musculus) | 6480464 | folpet results in increased expression of XPO7 mRNA | CTD | PMID:31558096 | Xpo7 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of XPO7 mRNA | CTD | PMID:22061828 | Xpo7 | Rat | irinotecan | decreases expression | ISO | XPO7 (Homo sapiens) | 6480464 | Irinotecan analog results in decreased expression of XPO7 mRNA | CTD | PMID:18927307 | Xpo7 | Rat | ivermectin | decreases expression | ISO | XPO7 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of XPO7 protein | CTD | PMID:32959892 | Xpo7 | Rat | L-methionine | multiple interactions | ISO | Xpo7 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of XPO7 gene | CTD | PMID:20938992 | Xpo7 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of XPO7 mRNA | CTD | PMID:30047161 | Xpo7 | Rat | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of XPO7 mRNA | CTD | PMID:25729387 | Xpo7 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of XPO7 mRNA | CTD | PMID:25729387 | Xpo7 | Rat | ozone | multiple interactions | ISO | XPO7 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPO7 mRNA more ... | CTD | PMID:32699268 and PMID:32845096 | Xpo7 | Rat | paracetamol | multiple interactions | ISO | Xpo7 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of XPO7 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of XPO7 mRNA] | CTD | PMID:17585979 | Xpo7 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of XPO7 mRNA | CTD | PMID:33387578 | Xpo7 | Rat | paracetamol | decreases expression | ISO | XPO7 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of XPO7 mRNA | CTD | PMID:21420995 | Xpo7 | Rat | parathion | decreases expression | ISO | Xpo7 (Mus musculus) | 6480464 | Parathion results in decreased expression of XPO7 mRNA | CTD | PMID:34813904 | Xpo7 | Rat | PCB138 | multiple interactions | ISO | Xpo7 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | Xpo7 | Rat | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of XPO7 mRNA | CTD | PMID:19162173 | Xpo7 | Rat | rotenone | increases expression | ISO | XPO7 (Homo sapiens) | 6480464 | Rotenone results in increased expression of XPO7 mRNA | CTD | PMID:33512557 | Xpo7 | Rat | sodium dichromate | increases expression | ISO | Xpo7 (Mus musculus) | 6480464 | sodium bichromate results in increased expression of XPO7 mRNA | CTD | PMID:31558096 | Xpo7 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of XPO7 mRNA | CTD | PMID:30047161 | Xpo7 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of XPO7 mRNA | CTD | PMID:34492290 | Xpo7 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of XPO7 mRNA | CTD | PMID:25729387 | Xpo7 | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of XPO7 mRNA | CTD | PMID:25729387 | Xpo7 | Rat | trichloroethene | decreases methylation | EXP | | 6480464 | Trichloroethylene results in decreased methylation of XPO7 gene | CTD | PMID:27618143 | Xpo7 | Rat | trichostatin A | increases expression | ISO | XPO7 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of XPO7 mRNA | CTD | PMID:24935251 | Xpo7 | Rat | valproic acid | decreases methylation | ISO | XPO7 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of XPO7 gene | CTD | PMID:29154799 | Xpo7 | Rat | valproic acid | decreases expression | ISO | XPO7 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of XPO7 mRNA | CTD | PMID:23179753 and PMID:29501571 | Xpo7 | Rat | valproic acid | affects expression | ISO | XPO7 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of XPO7 mRNA | CTD | PMID:25979313 | |